13 Oct 2021
Interested in the Meningococcal Vaccine?

Interested in the Meningococcal Vaccine?

Interested in the Meningococcal Vaccine?

There is one type of vaccine that is making the headlines these days, but there are others that are just as important, such as the Meningococcal Vaccine. If you are interested in learning more about this vaccine and participating in a clinical study for a new one, keep reading to find out more.

What is the Meningococcal Vaccine?

The Meningococcal Vaccine helps prevent meningococcal disease, which is any type of illness caused by Neisseria meningitides bacteria, according to the CDC. There are 2 types of meningococcal vaccines available in the United States:

  • Meningococcal conjugate or MenACWY vaccines (Menactra® and Menveo®)
  • Serogroup B meningococcal or MenB vaccines (Bexsero® and Trumenba®)

There is also a new Meningococcal Vaccine seeking FDA approval, and clinical trials are happening now.

All 11 to 12-year-olds should get a meningococcal conjugate vaccine, with a booster dose at 16 years old. Teens and young adults (16 through 23-year-olds) also may get a serogroup B meningococcal vaccine. CDC also recommends meningococcal vaccination for other children and adults who are at increased risk for meningococcal disease.

Participating in the Meningococcal Vaccine Clinical Study

Space for the Clinical Study is limited, however, you can still sign up today for the clinical study in Canoga Park and receive compensation for participating.

Here is how you get started:

  • Call 1-866-734-6052 or click here to join the Meningococcal Vaccine Clinical Trial. All volunteers will be able to review the Informed Consent Form, and the program will be carefully explained by our professional medical team.
  • Come in for a FREE Medical Exam. After evaluating your particular medical situation, we will invite you into our clinic for a comprehensive and complementary physical exam.
  • Participate in a Clinical Research Study with no special requirements. If you meet the physical guidelines of the study, you will be asked to participate. No insurance, social security number, or proof of citizenship is required.
  • Receive Up to $800! Participants will be assigned to different groups, where they will be carefully monitored for treatment and safety. As a volunteer, you will earn as much as $800 for completing the study.

Who Is Doing The Meningococcal Vaccine Clinical Study?

The clinical study is being conducted by Hope Clinical Research, a clinic located in Canoga Park, CA. Hope has extensive experience conducting Phase I through IV clinical trials with many leading pharmaceutical companies. The facility features investigators with extensive training and years in clinical research and counts over 10,000 patients.

Every member of the clinical research team offers a wealth of experience working at UCLA and USC., a caring personality, and a commitment to ably serving the pharmaceutical industry, the community, and its patients. In addition, our team speaks English, Spanish, Italian, and Farsi.

To learn more about the vaccine study or to see other open studies you can sign up for, visit us at clinicalresearchla.com.

Leave a Comment